Trazodone

Moderate Evidence

Also known as: Desyrel, Sleep aid, Trazodone

Overview

Trazodone is a prescription medication classified as a serotonin antagonist and reuptake inhibitor (SARI). It was originally developed and approved for the treatment of major depressive disorder (MDD), but in clinical practice it is also widely used for insomnia and sleep disturbance, particularly at lower doses. Its dual reputation—as an antidepressant at higher doses and a sedating medication at lower doses—has made it a familiar drug in both psychiatric and general medical settings.

Trazodone works through a combination of effects on brain signaling, especially serotonin pathways. It blocks certain serotonin receptors while also modestly inhibiting serotonin reuptake, and it has additional activity at histamine and alpha-adrenergic receptors, which helps explain its sedating properties and some of its side effects. Because of this pharmacology, trazodone occupies a somewhat distinct place among antidepressants: it is not used as commonly as selective serotonin reuptake inhibitors (SSRIs) for first-line depression treatment, but it remains clinically important for selected patients.

The medication is best known publicly for its use in sleep-related complaints, including difficulty falling asleep or staying asleep. However, the evidence base differs depending on the condition being considered. For major depressive disorder, trazodone has an established regulatory role and a substantial research history. For insomnia, studies suggest it may improve some sleep parameters in certain populations, but professional sleep medicine guidelines have generally viewed the evidence as more limited than for medications specifically approved for chronic insomnia.

As with many psychotropic medications, trazodone has meaningful benefits as well as important risks and cautions. Common adverse effects include drowsiness, dizziness, dry mouth, and orthostatic hypotension. More serious but less common concerns include cardiac rhythm effects, serotonin syndrome, suicidality warnings seen with antidepressants, and priapism, a rare but medically urgent prolonged erection. Because medication response varies by age, underlying health conditions, other prescriptions, and substance use, trazodone is generally discussed in the context of individualized care and monitoring by a qualified healthcare professional.

Western Medicine Perspective

In conventional medicine, trazodone is understood primarily as an antidepressant with sedative properties. Its FDA-approved indication is major depressive disorder, and randomized trials over several decades have evaluated its role in reducing depressive symptoms. Compared with newer antidepressants, trazodone is often considered less commonly used as a primary antidepressant because of its sedating effects and tolerability profile, though it may be useful in situations where depression coexists with insomnia, agitation, or poor sleep continuity.

In sleep medicine and general practice, trazodone is frequently prescribed off-label for insomnia. This pattern reflects real-world experience that the medication can promote sleep onset and maintenance in some individuals. At the same time, major professional organizations have noted that evidence for chronic insomnia is mixed and that lower-dose use for sleep has often outpaced high-quality long-term data. Studies indicate potential short-term benefit in selected patients, but concerns remain regarding daytime sedation, falls in older adults, cognitive effects, and interactions with other central nervous system depressants.

From a safety standpoint, conventional medicine emphasizes careful assessment of side effects, drug interactions, and patient-specific risk factors. Trazodone can contribute to orthostatic hypotension, impaired alertness, and rare but serious adverse events such as priapism and QT-related cardiac concerns in susceptible individuals. As with other antidepressants, labeling includes warnings about suicidal thoughts and behaviors in children, adolescents, and young adults during early treatment periods. Clinicians also evaluate for bipolar disorder, serotonin syndrome risk when combined with serotonergic agents, liver metabolism interactions, and the special considerations that apply in pregnancy, older age, and complex medical illness.

Overall, the western medical view is that trazodone is a legitimate, established medication with a stronger formal evidence base for depression than for insomnia, despite its widespread use for both. Its place in care is typically framed by diagnostic context, symptom pattern, side-effect tradeoffs, and ongoing monitoring rather than by a one-size-fits-all approach.

Eastern & Traditional Perspective

Eastern/Traditional Medicine Perspective

Traditional systems such as Traditional Chinese Medicine (TCM) and Ayurveda do not historically describe trazodone itself, since it is a modern pharmaceutical. However, these systems do offer frameworks for understanding the kinds of symptom patterns for which trazodone is often used—especially depressed mood, restlessness, anxiety, and insomnia. In this sense, an eastern perspective focuses less on the drug as a standalone entity and more on the underlying imbalance patterns associated with disturbed mood and sleep.

In TCM, insomnia and emotional distress may be interpreted through patterns such as Heart Shen disturbance, Liver qi stagnation, yin deficiency with heat, or disharmony between the Heart and Kidney systems. Sleep disruption accompanied by irritability, rumination, palpitations, or fatigue might be categorized differently depending on the broader symptom picture. Traditional approaches often involve individualized combinations of acupuncture, herbal formulas, breathing practices, and dietary patterning, with the goal of calming the spirit, regulating qi, and restoring systemic balance.

In Ayurveda, symptoms such as poor sleep, anxious thinking, depletion, or low mood may be viewed through disturbances in Vata, Pitta, or mental qualities such as rajas and tamas. Insomnia is often associated with nervous system overstimulation or depletion, while depressive symptoms may be interpreted according to constitutional type and digestive, energetic, and emotional patterns. Ayurvedic care traditionally draws on daily routine regulation, meditation, yoga, herbal preparations, oil therapies, and attention to digestion and stress load.

Naturopathic and integrative frameworks similarly tend to view sleep and mood complaints as multifactorial, involving stress physiology, circadian rhythm disruption, inflammation, nutrient status, trauma history, and lifestyle context. In integrative practice, trazodone may be considered one component within a larger picture rather than the sole focus. Because combining pharmaceuticals with herbs or supplements can create interactions—including additive sedation or serotonergic effects—integrative clinicians generally emphasize coordination with licensed healthcare providers when conventional and traditional approaches overlap.

Evidence & Sources

Moderate Evidence

Promising research with growing clinical support from multiple studies

U.S. Food and Drug Administration (FDA) Prescribing Information for trazodone
National Institute of Mental Health (NIMH)
American Psychiatric Association Practice Guideline for the Treatment of Patients With Major Depressive Disorder
American Academy of Sleep Medicine Clinical Practice Guideline for Pharmacologic Treatment of Chronic Insomnia in Adults
StatPearls
Cochrane Reviews
New England Journal of Medicine
Journal of Clinical Psychiatry

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.